Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00482300
Recruitment Status : Completed
First Posted : June 5, 2007
Last Update Posted : June 5, 2007
Information provided by:
University of Roma La Sapienza

Brief Summary:
The purpose of this trial is to determine whether the addition of systematic pelvic lymphadenectomy to hysterectomy with bilateral adnexectomy improves disease-free survival (DFS) and overall survival (OS) in patients with preoperatively supposed Stage I-II endometrial cancer

Condition or disease Intervention/treatment Phase
Endometrial Cancer Procedure: Systematic pelvic lymphadenectomy Not Applicable

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   up to 75 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Histologically proven endometrioid or adenosquamous endometrial carcinoma.
  • Patients having myometrial invasion
  • Age =/< 75 years
  • Informed consent.

Exclusion Criteria:

  • Serous papillary and clear cell tumors.
  • Karnofsky index < 80 or severe diseases contraindicating surgery
  • Concomitant neoplasia (basalioma cutis excluded)
  • Distant metastasis or abdominal metastasis detected intraoperatively.
  • Absence of myometrial invasion at frozen section.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00482300

Sponsors and Collaborators
University of Roma La Sapienza
Study Chair: Pierluigi Benedetti Panici, Full Professor Department of Obstetrics and Gynecology University La Sapienza of Rome

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00482300     History of Changes
Other Study ID Numbers: PTC-CBM-15
First Posted: June 5, 2007    Key Record Dates
Last Update Posted: June 5, 2007
Last Verified: March 2007

Keywords provided by University of Roma La Sapienza:
Histologically proved endometrial carcinoma preoperatively supposed stage I-II

Additional relevant MeSH terms:
Endometrial Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Uterine Diseases
Genital Diseases, Female